IDEXX Q3 diluted EPS rises 18% to USD 4.01; Q3 revenue climbs 10% to USD 1.21 billion

Description

(AWP Alliance News) - IDEXX Laboratories' third-quarter 2026 diluted earnings rose 18% year over year to USD 4.01 per share. Revenue increased 10% to USD 1.21 billion. The company raised its full-year 2026 earnings outlook to USD 14.96-USD 15.16 per share. It also lifted revenue guidance to USD 4.74 billion-USD 4.77 billion, citing strong commercial performance.

https://docs.publicnow.com/B1281EAB031CAB47D53564EF1C08FDE6EF3602AF

Disclaimer: This news brief was created using generative artificial intelligence. IDEXX Laboratories Inc. published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.